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Abstract The risk of exposure, progression to active tuberculosis (TB) and then to cure is
a process affected by several risk factors. Along with well known risk factors such as human
immunodeficiency virus (HIV), use of immunosuppressive drugs and being of young age, emerging
risk factors such socio-economic and behavioral aspects play a significant role in increasing the
susceptibility to infection, and unsuccessful treatment outcomes. This paper summarizes the
effects of these socio-economic determinants and co-morbidities (including HIV) on TB infection
and disease.
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Introduction
Tuberculosis (TB) control and elimination rely on an early
detection of active TB cases, prompt anti-TB treatment,
identification of persons in risk of exposure and infection and
prevention of secondary TB cases.1 All this depends on good
diagnosis methods and effective treatment regimens for TB,
but it is not enough.2 Socio-economic determinants of health
include the social, political, and economic conditions in
which people are born, develop, live, work, and age.3 Apart
from medical care, there is increasing evidence of the role
of these factors in health4,5 and TB epidemiology.6--8
The epidemiology of tuberculosis reflects how these
social determinants are distributed, with a clear influence in
all stages of TB pathogenesis: risk of exposure, susceptibility
to progression of disease, time to diagnosis and treatment,
compliance and successful treatment.6
Risk of exposure to Mycobacterium tuberculosis (MTB) is
dependent on social and risk behaviors. Living or working in
a high incident setting, overcrowding and poor ventilation
increase the risk of exposure.9 Factors that delay diagnosis
similarly increase the length of exposure to an infectious TB
patient.
Malnutrition increases the susceptibility to disease,10,11
income constraints can limit the use of health care
services.12 TB stigma, recognized as a social determinant
of health and health inequalities, associated with lack of
social support can potentially lead to non-compliance and
poor treatment outcome.13
In recent years, the role of risk factors and social deter-
minants of TB have been more intensively studied and
the role of some highly prevalent determinants such as
human immunodeficiency virus (HIV), smoking, diabetes
mellitus (DM), alcohol use and under-nutrition have been
highlighted.14 Others include overcrowding, housing condi-
tions or economic deprivation. It has been shown that the
areas with the highest TB incidence are also those with
high incidence of HIV infection, incarceration, overcrowd-
ing, unemployment and immigrants.15,16
The World Health Organization (WHO) has identified the
need for a holistic approach to TB, including the underly-
ing social-economic determinants of TB in order to achieve
elimination.17 This proposal is in line with the sustainable
development goals that put social inclusion together with
economic development and environmental sustainability as
common aims to be achieved for all countries by 2030.13
The objective of this paper is to offer an overview of
the different effects of socio-economic determinants on TB,
aiming to provide a better understanding of the complex
factors involved in the occurrence of the disease.
Methods
We searched PubMed and Scopus for studies written in
English, French, Spanish or Portuguese that evaluated the
socioeconomic determinants on TB. Broad search terms
included the following: tuberculosis, risk factors, and
socioeconomic determinants. Additional manuscripts were
selected from the references of the initially chosen arti-
cles. The WHO, the International Union Against Tuberculosis
and Lung Diseases (The Union), Centers for Disease Control
(CDC), and European Centre for Disease Prevention and Con-
trol (ECDC) websites were visited searching for publications
or reports regarding social determinants and TB.
Risk factors for TB infection, disease and
treatment default
Socioeconomic status can influence all stages of TB patho-
genesis. Risk of exposure is related to the underlying disease
burden and the environment in which people live.18 People
living or working in high burden places are at higher risk of
exposure. The characteristics of the environment, airflow
and number of people sharing the space will influence the
risk of exposure.8
Once the MTB infection has occurred, increased suscep-
tibility to disease can be related to co-morbidities such as
infection with human infection virus (HIV), diabetes, sili-
cosis or rheumatoid arthritis and other chronic illnesses or
immunosuppressive therapies but also to malnutrition, alco-
hol or tobacco abuse. An analysis that included the 22 High
TB Burden Countries estimated the population attributable
fraction of malnutrition (27%), smoking (23%), HIV (19%), dia-
betes (6%) and alcohol abuse (13%).19 The importance of the
risk factor depends on prevalence -- HIV is a more important
risk factor in high prevalent countries of Sub-Saharan Africa
(PAF > 50%).19
Health care costs associated with TB are both from direct
user fees charged at the healthcare centres and from indi-
rect costs of the visit. The money spent on transportation,
co-payments for medication, and loss of work due to a medi-
cal appointment are all indirect costs associated with the
use of health care services.20 These economic barriers may
cause a delay in contact to the health system where diagno-
sis is made,12 and high costs often constitute a catastrophic
economic burden for TB affected household.21
Successful treatment of TB involves taking anti-
tuberculosis drugs for at least six months. Low income,
alcohol abuse, HIV co-infection have been identified as pre-
dictive factors for default.19
Link between socioeconomic status and TB
Socioeconomic deprivation can be described as lacking
social and economic basic necessities.22 This is a complex
concept that includes a combination of factors, such as
lack of education, low income, overcrowding, and unem-
ployment, among others. The structural determinants and
the conditions in which people live are responsible for an
important part of health inequities22 and the increased risk
of TB.
Several studies have found an association between per
capita gross domestic product and TB incidence. Inclusion
of more proximal determinants in multivariate models indi-
cate that the impact of poverty on TB represent the effect
of multiple determinants and pathways.23 Socioeconomic
deprivation gives rise to poor living conditions, overcrowd-
ing, and undernutrition which increases the risk of exposure
to a TB case, increases vulnerability to disease and risk of
bad treatment outcome.23--25
Tuberculosis, social determinants and co-morbidities (including HIV) 117
The association between TB and homelessness has long
been recognized and studies have reported a higher risk
of TB and lower treatment success rate in this group of
patients.26--28 However, predictors of unsuccessful treatment
among these patients were age, intravenous drug use and
HIV co-infection.27
Overcrowding has been also associated with higher risk
of exposure to TB. Housing conditions can affect the risk
of exposure through poor ventilation or the quality of the
indoor air.29 Significant associations have been identified
with overcrowding and TB notification.18
An additional risk factor for tuberculosis is poor nutri-
tional status. There is a clear dose--response relationship
between degree of undernutrition and risk of TB incidence.11
Undernutrition is also a consequence of TB and undernutri-
tion at time of diagnosis is associated with higher risk of
death, although there is insufficient data to judge if food
or supplements as an adjuvant to anti-TB medicines can
improve TB treatment outcomes.30
People facing socioeconomic deprivation have a higher
risk of contact with people with TB, higher likelihood of
living and working in crowded and badly ventilated places,
higher risk of malnutrition, less healthy behaviors (smoking,
alcohol abuse) and face barriers to accessing health care.8
Migration has been pointed as a risk factor for TB,
particularly among migrants originating from high burden
countries. But other conditions may have an impact on the
higher risk. Deprived conditions, overcrowding, malnutri-
tion, poor access to health care have been described in
mobile communities.31
Injecting drug users have a higher risk for TB due to
socioeconomic and risky behaviors, such as deprivation,
homelessness, imprisonment, HIV infection and malnutri-
tion. They also face barriers to health care due to ill
perception of disease.31,32
Tobacco and alcohol
There is increasing evidence of tobacco effect on TB. Recent
studies indicate that active and passive tobacco smoking
are risk factors for latent tuberculosis infection, progres-
sion to active disease and lower rates of treatment success
and higher TB-related death. Additionally, smoking has
been associated with more frequent cavitation and bilateral
radiological findings, higher bacillary load, delay of smear
and culture conversion, higher risk of reactivation.29,33 Other
studies identified a dose--response relation between number
of cigarettes smoked, years of smoking and tuberculosis.34,35
Smoking cessation has been associated with higher cure
rates (highest among non-smokers) when compared with
smokers.36 It has been recommended that smoking cessation
programs should be part of TB control plans.36--38
The causal relation between heavy alcohol use and TB has
long been described, but only recently has it been possible to
estimate the alcohol attributable disease burden. According
to new estimates, 17% of TB cases and 15% of deaths due to
TB could have been prevented if there had not been heavy
alcohol consumption.39
Many studies have looked at the effect of alcohol abuse
on TB with a consistent association of alcohol abuse and
more contagious and severe manifestations of the disease.
Alcohol consumption above 40 g of ethanol per day or a diag-
nosis of an alcohol disorder resulted in a nearly three-fold
increased risk for TB.40 Excessive alcohol consumption has
also been associated with a higher risk of smear-positivity,
cavitary disease, longer time to smear conversion, increased
risk of drug toxicity, poor adherence and death due to
TB.40--42
Alcoholism has also been linked to other socioeconomic
determinants such as low socioeconomic status, homeless-
ness and malnutrition, all of them independent risk factors
for TB and treatment failure.
HIV
On top of the socioeconomic factors, other TB risk fac-
tors have also already been widely described. Among them,
infection with HIV stands out.
It is known that HIV-infected patients have a higher risk
for TB development compared to persons without HIV. The
incidence is higher in patients with lower CD4+ T cell count
and detectable viral load but other risk factors might play a
role, such as diabetes, alcohol, malnutrition, homelessness,
IV-drugs use, hepatitis C, tobacco smoke.43--46
In patients with overlapping health issues, having effec-
tive strategies to deliver HIV, TB and drug dependency care
in combination are crucial. Portugal’s experience shows that
integration is possible and depends on four key factors: col-
laborative networks and shared protocols; involvement of
outreach teams; provision of uninterrupted opioid substitu-
tion therapy; and flexibility over treatment location.47
Over recent years there has been a move toward early
initiation of antiretroviral therapy (ARV) during treatment
for tuberculosis, given that the results of several trials have
shown that this strategy significantly reduces mortality and
morbidity due to HIV and TB.48 However, when we look at
latent TB the scenario is a bit different. For several years
WHO has strongly recommended screening for latent TB and
scaling up preventive isoniazid treatment in all HIV patients,
regardless of TB incidence in the country. However, it is
not known what the implementation of this recommenda-
tion is overall. Data from ECDC show that in 2014, 142,197
newly diagnosed HIV infections were reported in the WHO
European Region, but only 21,000 (14.7%) were provided
with TB preventive therapy.49 Several factors might explain
the low coverage of screening among HIV patients. Evenblij
et al. in Netherlands shed some light on this problem, using
quantitative and qualitative methods to understand the dis-
connection between clinical practice and evidence-based
recommendations concerning screening and treatment of TB
latent infection.25
Comment
Socioeconomic determinants have an effect on degree of
exposure, risk behaviors and access to health care. TB
additionally has a negative effect on the productivity and
socioeconomic status of the individual.
The identification of the risk factors and determinants
of tuberculosis is particularly important as an increasing
number of low and middle-income countries enter a phase
of epidemiological transition where non-communicable
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diseases and conditions replace infectious diseases as main
causes of ill health and deaths. The existing relationship
between non-communicable conditions and TB demands
holistic strategies and interventions. Actions directed at the
reduction of smoking, poverty, undernutrition, and better
living conditions can have an important impact on TB con-
trol. Screening and management of common comorbidities
and risk behaviors that increase risk of poor TB outcomes
is important in order to optimize clinical care. Conversely,
screening for TB in high-risk groups should be considered.50
Social interventions are often needed to enable TB
patients to access care and adhere to treatment.51 Most of
these interventions will require interdisciplinary collabora-
tion as well as intervention from outside the health sector.
Although there is limited evidence on the best interventions,
it is proposed that actions aimed to increase social protec-
tion; livelihoods strength or urban renovations may have an
impact on TB epidemiology.6
At the present time, in HIV population, defining who,
when and how frequently latent TB should be screened
are the questions that remain to be answered. Should we
define subsets of patients to be screened according to CD4+
count, viral load, country of origin? Should we repeat annual
screening even in countries with intermediate or low level
TB incidence? Which is the most cost effective strategy to
adopt in each setting? These questions must be answered by
new studies that evaluate in an integrated way the best care
practices with the social factors that impact TB occurrence
and the search for care by the patient with TB.
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